April Chen
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Pharmacology 10
- Antibiotics Pharmacokinetics and Efficacy 9
- Pharmacogenetics and Drug Metabolism 2
- Drug-Induced Hepatotoxicity and Protection 2
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- Alita A. Miller (6 shared papers)Nicole Carter (3 shared papers)Adam B. Shapiro (4 shared papers)John P. O’Donnell (5 shared papers)Rubén Tommasi (5 shared papers)Ning Gao (1 shared paper)Haris Jahić (1 shared paper)Sarah M. McLeod (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Xenobiotica (2 papers)ACS Infectious Diseases (2 papers)Drug Metabolism and Disposition (2 papers)ACM Transactions on Knowledge Discovery from Data (1 paper)
- Partner nations
- United StatesFranceBrazil
In The Last Decade
April Chen
16 papers receiving 332 citations
Peers
Comparison fields: 5 of 61
- Molecular Medicine 188
- Applied Microbiology and Biotechnology 33
- Pharmacology 114
- Hepatology 27
- Pharmacology 30
Countries citing papers authored by April Chen
This map shows the geographic impact of April Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April Chen more than expected).
Fields of papers citing papers by April Chen
This network shows the impact of papers produced by April Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April Chen. The network helps show where April Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside April Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 67 | |
| 2 | 2017 | 53 | |
| 3 | 2020 | 49 | |
| 4 | 2008 | 47 | |
| 5 | 2009 | 33 | |
| 6 | 2017 | 21 | |
| 7 | 2023 | 18 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 14 | |
| 10 | 2023 | 8 | |
| 11 | 2024 | 8 | |
| 12 | 2012 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2015 | 3 | |
| 15 | 2025 | 2 | |
| 16 | 2023 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About April Chen
April Chen is a scholar working on Pharmacology, Molecular Medicine, Oncology, Epidemiology and Molecular Biology, having authored 18 papers that have together received 352 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Antibiotic Resistance in Bacteria (7 papers), Pneumonia and Respiratory Infections (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Molecular Medicine (188 citations), Applied Microbiology and Biotechnology (33 citations), Pharmacology (114 citations), Hepatology (27 citations) and Pharmacology (30 citations). April Chen has collaborated with scholars based in United States, France and Brazil. Frequent co-authors include Alita A. Miller, Nicole Carter, Adam B. Shapiro, John P. O’Donnell, Rubén Tommasi, Ning Gao, Haris Jahić, Sarah M. McLeod, John P. Mueller and David P. Nicolau. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Xenobiotica, ACS Infectious Diseases, Drug Metabolism and Disposition and ACM Transactions on Knowledge Discovery from Data.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.